IL1B and myeloid sarcoma: Persistent microglial activation releases cytokines such as IL-1β and TNF-α, creating a neuroinflammatory milieu that drives the synaptic dysfunction and oxidative stress—processes implicated in both MS neurodegeneration and various dementias (37, 38).